Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients

February 6, 2024 updated by: Contipro Pharma a.s.
The main objective of the trial is to confirm safety of a new product - Epipad. The main impact of the device is to provide good environment for the healing of chronic wounds and wounds in the last healing phase (granulation and epithelisation).

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brno, Czechia
        • Fakultni nemocnice u sv. Anny
      • Hořice, Czechia
        • Levitovo centrum nasledne pece
      • Olomouc, Czechia
        • Vojenska nemocnice Olomouc
      • Vsetín, Czechia
        • Vsetinska nemocnice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient suffered from superficial wound of different etiology
  • Wounds in terminal phase of healing
  • Wounds without visible sign of infection
  • Max. size of the wound: 10 x 20 cm (i.e. two pieces of the product)
  • Duration of wound treatment of at least 6 weeks
  • Subject willing and able to provide written informed consent
  • Ability to communicate well with the investigator in local language, and to understand and comply with the requirements of the study

Exclusion Criteria:

  • Sloughy or necrotic wound bed
  • Severely contaminated or infected wound
  • Age < 18 years
  • Pregnant or lactating woman
  • Subject in terminal stage of living
  • Subject with cancer disease
  • Subject with known hypersensitivity or allergy to any component of the investigational device
  • Subject participating in other interventional clinical trial
  • Alcohol and/or drug abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients treated with Epipad
Epipad
Device is placed directly onto the treated wound. The wound should be cleaned with antiseptic solution prior to the device administration. The device is fixed on the wound by secondary dressing: e.g. plaster, compression.
Other Names:
  • Epipad

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the wound dimensions (width x length)
Time Frame: Week 3
Change in the wound dimensions from baseline
Week 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 26, 2022

Primary Completion (Actual)

October 31, 2023

Study Completion (Actual)

October 31, 2023

Study Registration Dates

First Submitted

November 9, 2022

First Submitted That Met QC Criteria

November 9, 2022

First Posted (Actual)

November 16, 2022

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe